# Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance

> **NCT00264251** · NA · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 48 (estimated)

## Conditions studied

- HIV Infections
- Insulin Resistance
- Obesity

## Interventions

- **BEHAVIORAL:** Weight loss through diet and exercise
- **DRUG:** Rosiglitazone insulin sensitizing agent

## Key facts

- **NCT ID:** NCT00264251
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2007-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264251, "Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00264251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*